Menu Search
Equities

M&A Research Institute Holdings Inc

MAARF:PKL

M&A Research Institute Holdings Inc

Actions
  • Price (USD)14.34
  • Today's Change-0.73 / -4.84%
  • Shares traded284.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 05 2024 19:45 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

M&A Research Institute Holdings Inc, formerly M&A Research Institute Inc, is a Japan-based company mainly engaged in the provision of merger and acquisition (M&A) brokerage services and web marketing support services. The Company operates through two business segments. The M&A Intermediary segment is mainly engaged in the provision of M&A intermediary services using artificial intelligence (AI) matching algorithms. The Others segment is mainly engaged in the provision of web marketing support services, leveraging its expertise in attracting web customers through M&A intermediary services.

  • Revenue in JPY (TTM)16.55bn
  • Net income in JPY5.79bn
  • Incorporated2018
  • Employees258.00
  • Location
    M&A Research Institute Holdings Inc17F Marunouchi Trust Tower N Kan1-8-1 MarunouchiCHIYODA-KU 100-0005JapanJPN
  • Websitehttps://masouken.com/holdings/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.